Carl Icahn Reports HUGE Stake In Herbalife
Icahn told CNBC's Scott Wapner that he's done a great deal of research on the company and he doesn't think that it's a pyramid scheme.
Herbalife is the stock that Icahn's decade-long rival Bill Ackman, the CEO of $12 billion Pershing Square Capital Management, is shorting. Ackman, who is shorting more than 20 million shares, believes that the company is a "pyramid scheme" and has a price target of $0.
Just last month, the two hedge fund titans, who have been fighting for a decade, duked it out on CNBC in a live telephone interview with Icahn hurling brutal insults at Ackman.
The stock is soaring on the Icahn news. Herbalife is up 18.11%, or $45.20 per share, in after-hours trading. That's above the pre-Ackman short level.